Clinical Trials Logo
  1. Home
  2. Morality
  3. NCT03089359
  4. Details
NCT03089359 Clinical Trial

Prehospital Recognition and Identification of Unspecific Symptoms

Morality Clinical Trial

— PRIUS  

Official title:
Prehospital Recognition and Identification of Unspecific Symptoms

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03089359
Other study ID # PRIUS
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 4, 2015
Est. completion date March 23, 2021

Study information
Verified date March 2021
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.

Recruitment information / eligibility
Status Completed
Enrollment 414
Est. completion date March 23, 2021
Est. primary completion date March 23, 2021
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Unspecific symptoms (not feeling well, decreased general health condition, unable to cope with usual daily activities, feeling weak) - Normal vital signs - Transported to ED - Able to give informed consent/ Next of kin gives informed consent Exclusion Criteria: - Specific symptoms - under 18 years of age - Stays home / other caregiver than ED - Referral from caregiver - No personal numer (social security number)

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Finland Helsinki University Helsinki
Sweden Karolinska Institute Stockholm

Sponsors (1)
Lead Sponsor Collaborator
Karolinska Institutet

Countries where clinical trial is conducted

Finland,  Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Serious condition Predefined serious condition During medical care event
Secondary Mortality 24h and 30 day mortality 24hours and 30 days
See also
  Status Clinical Trial Phase
Completed NCT03079726 - Use of Device Data to Predict Frailty in Individuals
Not yet recruiting NCT05447611 - Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.
Completed NCT05268419 - Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study) Phase 3
Completed NCT05042804 - Perioperative Outcome Risk Assessment With Computer Learning Enhancement N/A
Recruiting NCT03628313 - Valvular Aortic Stenosis Prognosis Study
Completed NCT05527678 - 5 Years Quality of Life and Early Mobilization in ICU
Recruiting NCT05088109 - Shock Indices Use for Early Mortality From Septic Shock
Recruiting NCT05073991 - Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
Completed NCT05844410 - Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
Recruiting NCT05585593 - Registry for Hypoparathyroidism Wuerzburg
Recruiting NCT03834246 - Smoke Inhalation Injury in Patients Admitted to Intensive Care
Completed NCT03919032 - Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics
Completed NCT05116670 - Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
Withdrawn NCT04531839 - Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement N/A
Recruiting NCT04685278 - Anticardiolipin Autoantibodies and Mortality in Septic Patients
Not yet recruiting NCT03665987 - The Effect of Preoperative Assessment Clinic on Prognosis and Economic Results of Patients With Coexisting Disease.
Completed NCT04049565 - CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
Completed NCT04971278 - Evaluating the Impact of a Supportive Care Program
Recruiting NCT06087315 - Evaluation of a Multi-country Medical Oxygen Program
Completed NCT03344627 - Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients N/A